Navigation Links
MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
Date:3/4/2008

es affiliated with

Deerfield Management pursuant to the Keflex transaction, resulting from

MiddleBrook's consolidation of the two affiliates under Financial

Accounting Standards Board Interpretation No. 46 (revised 2003)

"Consolidation of Variable Interest Entities."

-- Net loss per share applicable to common stockholders for the fourth

quarter of 2007 was ($0.19), compared to a loss per common share of

($0.22) in the prior quarter and ($0.44) in the fourth quarter of 2006.

For the fiscal year of 2007, net loss per share applicable to common

stockholders was ($0.96), down from ($1.38) for the fiscal year of

2006.

Per share figures were computed on the basis of an average of 46.7

million shares outstanding in the fourth quarter of 2007, 46.7 million

shares outstanding in the third quarter of 2007, 31.5 million shares

outstanding in the fourth quarter of 2006; and 43.8 million shares

outstanding for the full year of 2007 and 30.5 million shares

outstanding for the full year of 2006.

-- Cash and marketable securities decreased by $4.0 million during the

fourth quarter. Changes were composed of $6.9 million of operating

losses, $4.9 million in loan payments, and $2.3 million for working

capital changes and other items; offset by $7.0 million raised from the

Deerfield Management Keflex transaction and $3.1 million for non-cash

expenses.

-- The Balance Sheet at the end of 2007 reflected $2.0 million of

unrestricted cash, cash equivalents and marketable securities, compared

to $15.4 million as of year-end 2006. Following the fourth quarter of

2007, MiddleBrook completed a private placement of common stock and

warrants resulting in the addition of $19.9 million of net proceeds to

the Company.

FINANCIAL GUIDANCE

Total r
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million
2. MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008
3. MiddleBrook Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Financial Results on March 4, 2008
4. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
5. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
9. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
10. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Nashville, Tenn. (PRWEB) December 23, 2014 ... Hill was elected treasurer for the American Society ... to advancing knowledge and research in reproductive medicine. ... fills a seat on the executive board and will ... , Dr. Hill has actively supported ASRM since ...
(Date:12/24/2014)... BEIJING , Dec. 23, 2014 ... or the "Company"), a leading fully integrated plasma-based ... today announced that its majority-owned subsidiary, Shandong Taibang ... Practices ("GMP") certification from the China Food and ... factor production facility. As previously disclosed in the ...
(Date:12/24/2014)... , Dec. 23, 2014 Sigma-Aldrich Corporation ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements ... expired on December 22, 2014, thereby completing the ... for the acquisition of the Company by Merck ... clearance satisfies another condition to closing the transaction, ...
(Date:12/22/2014)... The Center for Professional Innovation ... training across the life sciences industry, has partnered with ... to provide the organization's members with discounted classroom courses, ... the more than 350 sessions across 80 course titles. ... when registering for a public course at ...
Breaking Biology Technology:Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3
... a leading clinical stage biotechnology company with offices ... proprietary stem cell and tissue engineering based therapies, ... Administration (FDA) to initiate a Phase I clinical ... treatment of Critical Limb Ischemia (CLI). The FDA ...
... diamond-like lattice composed of gold nanoparticles and viral particles, ... DNA. The structure a distinctive mix of hard, ... linked by the very stuff of life, DNA ... an assortment of materials to create infinitesimal devices. ...
... Mass., Jan. 27, 2011 Waters Corporation (NYSE: ... of NuGenesis® Scientific Data Management System 7.1 Service ... Windows 7, both Professional and Enterprise 32bit versions, ... (CDS).   Additionally, the NuGenesis SDMS ...
Cached Biology Technology:Arteriocyte Receives FDA Approval to Move Forward with Critical Limb Ischemia Trial 2Arteriocyte Receives FDA Approval to Move Forward with Critical Limb Ischemia Trial 3A mix of tiny gold and viral particles -- and the DNA ties that bind them 2Waters Releases NuGenesis SDMS 7.1 Validated to Support Windows 7 and Empower 3 CDS 2
(Date:12/22/2014)... -- The 2014 Holiday Season may be the brightest ... Intelligence reports that the long anticipated floodgates for ... that intensifying demand for smart phones, tablets, and ... a global market of 2.5 billion users with ... According to Maxine Most , ...
(Date:12/19/2014)... 18, 2014  23andMe, Inc., the leading personal genetics ... pinpoints fine-scale differences in genetic ancestry of individuals from ... Since immigrants first arrived more than four hundred ... has served as a meeting place for peoples from ... the ongoing mixing of peoples with African, European, and ...
(Date:12/17/2014)... , Dec. 15, 2014 The ... make it easier to detect and prevent counterfeit ... Today the agency started performing an in-house ... will validate the authenticity of purchased microcircuits while ... new quality control measures will be conducted at ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3
... SAN FRANCISCO -- Researchers looking into the ... that after an eight-week program, study participants demonstrated ... gait, and increased strength and endurance. The ... VA Medical Center in Indianapolis, Indiana University-Purdue University ...
... atomic hydrogen gas the ultimate fuel for stars ... Dr Robert Braun has found.,This is the first accurate measurement ... Just after the Big Bang the Universe,s matter was almost ... together and generated galaxies, stars and planets and the ...
... a fjord in Canada scientists have found a landscape similar ... a frozen and sulphurous environment, where sulphur associated with Arctic ... for traces of life on Europa. It is ... and sulphur come together, supposedly like on Europa, Jupiter,s moon. ...
Cached Biology News:Study: In-patient, out-patient stroke rehab might benefit from yoga 2There's more star-stuff out there but it's not dark matter 2Arctic bacteria help in the search to find life on moon Europa 2
Rabbit polyclonal to ZA20D3 ( Abpromise for all tested applications). entrezGeneID: 54469 SwissProtID: Q6FIF0...
... Super-Dark, Super-Small! Capture high-resolution chemiluminescent ... Imaging System. High-sensitivity camera is cooled ... and wide dynamic range for high ... time. The light-tight cabinet provides optimum ...
Rabbit polyclonal to TAB1 ( Abpromise for all tested applications). entrezGeneID: 10454 SwissProtID: Q15750...
Rabbit polyclonal to NIRF ( Abpromise for all tested applications). Antigen: Synthetic peptide derived from residues 186-235 of human NIRF. Entrez Gene ID: 115426 Swiss Protein ID: Q96PU...
Biology Products: